Diabetes Market Research Reports & Industry Analysis
Glucose monitors have a major consumer-marketing component. While physicians may prescribe a monitor, the patient ultimately has the choice of which monitor s/he uses. Insulin provides very little consumer choice. The treatment regimen prescribed by the physician must be followed and there are very few market options. With Eli Lilly and Novo Nordisk being the two largest producers of insulin, it is highly likely that an insulin user will wind up using one of their products. As time goes by, the options of oral insulin and more intranasal insulin products may offer insulin dependent diabetics more variety in terms of products and delivery methods.
Hypoglycemic agents abound and vary in their composition and mode of action. For the most part, advanced cases of Type 2 diabetes require more than one of these drugs in order for the patient to maintain glycemic control. Because of the wide variety of these products, there is some room for pharmaceutical companies to influence diabetics toward using their products. In the end, the physician may have the last word, but that does not mean that the patient will stay with a physician who does not acquiesce to his/her wishes.
Diabetes Industry Research & Market Reports
-
Europe Continuous Glucose Monitoring Systems Market: Market Size, Forecast, Insights, Segmentation, and Competitive Landscape with Impact of COVID-19 & Russia-Ukraine War
... of around 9.2% during 2025-2034. This report on Europe continuous glucose monitoring systems market report provides holistic understanding of the market along with market sizing, forecast, drivers, challenges, and competitive landscape. The report presents a ... Read More
-
Endocrinology Drugs Market by Therapy Area (Adrenal Insufficiency, Diabetes, Growth Hormone Disorders, Other Therapy Areas), Drug Class, Distribution Channel, and Geography - Global Industry Analysis, Opportunities and Forecast up to 2030
... The global endocrinology drugs market size was valued at $98.31 billion in 2024 and is projected to reach $145.89 billion by 2030, growing at a CAGR of 6.8% during the forecast period. Endocrinology Drugs Market ... Read More
-
Metabolic Disorder Therapeutics
... by 2030, growing at a CAGR of 6.8% over the analysis period 2023-2030. Diabetes Therapeutics, one of the segments analyzed in the report, is expected to record a 7.2% CAGR and reach US$91.9 Billion by ... Read More
-
Smart Insulin Pens and Pumps
... is expected to reach US$9.2 Billion by 2030, growing at a CAGR of 8.6% over the analysis period 2023-2030. Smart Insulin Pumps, one of the segments analyzed in the report, is expected to record a ... Read More
-
Impact of Covid-19 on Pharmaceuticals Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2024-2032
... of Covid-19 on the pharmaceuticals market size was valued at USD 1,494.67 billion in 2021, and the market is now projected to grow from USD 1,585.05 billion in 2022 to USD 2,401.22 billion by 2029, ... Read More
-
Diabetic Foot Ulcers and Pressure Ulcers
... the year 2023, is expected to reach US$6.0 Billion by 2030, growing at a CAGR of 4.4% over the analysis period 2023-2030. Diabetic Foot Ulcers, one of the segments analyzed in the report, is expected ... Read More
-
Desmopressin
... of 5.5% over the analysis period 2023-2030. Injectable Solution, one of the segments analyzed in the report, is expected to record a 6.1% CAGR and reach US$866.1 Million by the end of the analysis period. ... Read More
-
Insulin Pens
... at a CAGR of 7.1% over the analysis period 2023-2030. Disposable Insulin Pens, one of the segments analyzed in the report, is expected to record a 7.7% CAGR and reach US$11.6 Billion by the end ... Read More
-
Diabetic Shoes
... at a CAGR of 8.1% over the analysis period 2023-2030. Online Distribution Channel, one of the segments analyzed in the report, is expected to record a 8.4% CAGR and reach US$10.6 Billion by the end ... Read More
-
Type 2 Diabetes - Pipeline Insight, 2024
... pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. ... Read More
-
Insulin Pen Needles
... by 2030, growing at a CAGR of 6.7% over the analysis period 2023-2030. Standard Insulin Pen Needles, one of the segments analyzed in the report, is expected to record a 6.3% CAGR and reach US$2.7 ... Read More
-
Diabetes Injection Pens
... by 2030, growing at a CAGR of 5.7% over the analysis period 2023-2030. Insulin Pens, one of the segments analyzed in the report, is expected to record a 6.1% CAGR and reach US$8.2 Billion by ... Read More
-
Oral Proteins & Peptides Market by Molecule (Semaglutide, Linaclotide, Calcitonin), Drug Class (GLP-1 Receptor Agonist, GEP, CGRP), Therapeutic Area (Diabetes, Gastroenterology, Genetic Disorder), Formulation (Tablet, Capsule) - Global Forecast to 2029
... and peptides market is projected to reach USD 20.36 billion by 2029 from USD 7.38 billion in 2024, at a CAGR of 22.5% during the forecast period of 2024 to 2029. The growth of the ... Read More
-
Clinical Decision Support System Market Research Report Information by Component (Software, Services, and Hardware) By Product (Integrated CDSS and Standalone CDSS), By Model (Knowledge-Based CDSS and Non-Knowledge-Based CDSS), By Delivery Mode (On-Premise CDSS and Cloud-Based CDSS), By Mode of Advice (Active CDSS and Passive CDSS), By Setting (Inpatient Settings and Ambulatory Care Settings) By Type (Therapeutic Clinical Decision Support Systems and Diagnostic Clinical Decision Support Systems ), By Application (Advanced Clinical Decision Support Systems and Conventional Clinical Decision Support Systems), By Region (North America, Europe, Asia-Pacific, and Rest of the World) - Industry Forecast till 2032
... CDSS), By Mode of Advice (Active CDSS and Passive CDSS), By Setting (Inpatient Settings and Ambulatory Care Settings) By Type (Therapeutic Clinical Decision Support Systems and Diagnostic Clinical Decision Support Systems ), By Application (Advanced ... Read More
-
Pet Diabetes Care Devices Market: Global Market Size, Forecast, Insights, Segmentation, and Competitive Landscape with Impact of COVID-19 & Russia-Ukraine War
... of around 7.1% during 2025-2034. This report on global pet diabetes care devices market report provides holistic understanding of the market along with market sizing, forecast, drivers, challenges, and competitive landscape. The report presents a ... Read More
-
2024 North America Blood Glucose Test Strips Market Forecast (2025-2030 Outlook)-Market Opportunities Report
... the NAICS Healthcare industry. market is expected to increase from USD xx billion in 2025 to USD xx billion by 2030, at a CAGR of xx% from 2025 to 2030. Estimates on product and service ... Read More
-
2024 Global Blood Glucose Test Strips Market Forecast (2025-2030 Outlook)-Market Opportunities Report
... NAICS Healthcare industry. market is expected to increase from USD xx billion in 2025 to USD xx billion by 2030, at a CAGR of xx% from 2025 to 2030. Estimates on product and service sales ... Read More
-
Glucose Meter Manufacturing in the US - Industry Market Research Report
... The American Diabetes Association (ADA) reports that there are about 8.5 million individuals with undiagnosed diabetes, providing manufacturers with a large potential customer base. Diabetic patients use glucose meters to manage their glucose levels, as ... Read More
-
2024 Asia-Pacific Blood Glucose Test Strips Market Forecast (2025-2030 Outlook)-Market Opportunities Report
... NAICS Healthcare industry. market is expected to increase from USD xx billion in 2025 to USD xx billion by 2030, at a CAGR of xx% from 2025 to 2030. Estimates on product and service sales ... Read More
-
2024 United States Blood Glucose Test Strips Market Forecast (2025-2030 Outlook)-Market Opportunities Report
... the NAICS Healthcare industry. market is expected to increase from USD xx billion in 2025 to USD xx billion by 2030, at a CAGR of xx% from 2025 to 2030. Estimates on product and service ... Read More
-
Asia Pacific Blood Glucose Monitoring Market Research Report Information, By Product Type (Invasive Glucose Monitoring, Flash Glucose Monitoring, and CGM), By Application (Type 1 Diabetes, and Type 2 Diabetes), By End-User (Diagnostics Center, Hospitals, and Clinics), And, By Region (Asia-Pacific) –Industry Forecast till 2032
... Clinics), And, By Region (Asia-Pacific) –Industry Forecast till 2032 The Asia Pacific Blood Glucose Monitoring Market was valued at USD 1.1 billion in 2022. The Asia Pacific Blood Glucose Monitoring market is expected to increase ... Read More
-
Insulin Delivery Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update
... and Countries, Regulatory Path and Key Companies, 2024 Update provides comprehensive information about the Insulin Delivery pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials ... Read More
-
Global Blood Glucose Monitoring Devices Market - Focused Insights 2024-2029
... Blood Glucose Monitoring Systems Diabetes become the leading cause of death; so far, there are no effective treatments to prevent and cure diabetes, so reasonable blood glucose monitoring devices become a major choice. It led ... Read More
-
Germany Diabetes Device Market Forecast Report by Types (Self-Monitoring Devices, Continuous Glucose-Monitoring Devices, Insulin Pumps, Insulin Pens), End User (Hospitals, Diagnostics Centers, Homecare) and Company Analysis 2024-2032
... Device market is expected to reach US$ 1.39 Billion in 2023 to US$ 2.62 Billion by 2032, with a CAGR of 7.30 % from 2024 to 2032. The wide variety of applications available for diabetes ... Read More
-
United States Diabetes Device Market Forecast Report by Types (Self-Monitoring Devices, Continuous Glucose-Monitoring Devices, Insulin Pumps, Insulin Pens), End User (Hospitals, Diagnostics Centers, Homecare), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Diabetes Clinics/Centers, Online Pharmacies) and Company Analysis 2024-2032
... Company Analysis 2024-2032 United States Diabetes Device Market Size The United States Diabetes Device market is expected to reach US$ 8.67 Billion in 2023 to US$ 16.25 Billion by 2032, with a CAGR of 7.23 ... Read More
Research Assistance
